Evolution ofM. bovisBCG Vaccine: Is Niacin Production Still a Valid Biomarker?
نویسندگان
چکیده
منابع مشابه
Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?
BCG vaccine is usually considered to be safe though rarely serious complications have also been reported, often incriminating contamination of the seed strain with pathogenic Mycobacterium tuberculosis. In such circumstances, it becomes prudent to rule out the contamination of the vaccine seed. M. bovis BCG can be confirmed by the absence of nitrate reductase, negative niacin test, and resistan...
متن کاملPsychological contracting: is it still a valid concept?
In dynamic change environments the concept of the psychological contracts is tested as organisations pursue more transactional relationships with their employees and as employees are encouraged to pursue protean careers. With such increased emphasis on self-serving personal and organisational strategies, one may question whether a ‘psychological contract’ continues to serve a useful purpose in ...
متن کاملIs Credé's prophylaxis for ophthalmia neonatorum still valid?
This section looks back to some ground-breaking contributions to public health, reproducing them in their original form and adding a commentary on their significance from a modern-day perspective. To complement the theme of this month’s Bulletin, Ulrich C. Schaller and Volker Klauss review the 1881 paper by Carl S.F. Credé on the use of silver nitrate for the treatment of neonatal inflammatory ...
متن کاملEstimating immunisation coverage: is the 'third dose assumption' still valid?
Immunisation coverage is calculated from Australian Childhood Immunisation Register (ACIR) data using the 'third dose assumption'. This assumes that if the third in a series of vaccine doses has been recorded on the ACIR, the previous two doses have been received, whether or not they are recorded. The objectives of this study were to validate the 'third dose assumption', and measure the impact ...
متن کاملNeopterin: still a forgotten biomarker.
To the Editor: We read with interest the recent authoritative review article by Apple et al. (1) regarding biomarkers and acute coronary syndromes (ACS). Although the article is both exhaustive and clinically relevant, we felt that the authors failed to recognize the potential value of neopterin as a marker of cardiovascular risk. Neopterin, a pteridine derivative produced by activated macropha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tuberculosis Research and Treatment
سال: 2015
ISSN: 2090-150X,2090-1518
DOI: 10.1155/2015/957519